Beaumont Hospital in Royal Oak, MI recently announced that they have begun to use SpaceOAR hydrogel for patients undergoing radiation therapy for prostate cancer.
As Michigan’s largest health care system based on inpatient admissions and net patient revenue, Beaumont Hospital strives to give patients compassionate, top notch care. They are committed to adding health care improvements that they know will be beneficial to their patients.
The hydrogel is placed by Dr. Daniel Krauss, MD., a radiation oncologist with a primary focus on prostate and bladder cancers. He places the gel under local or general anesthesia in an outpatient setting. He is a leading expert in prostate cancer treatment with brachytherapy, a high-dose, internal radiation treatment.“Treating prostate cancer with radiation therapy can cause unintended injury to adjacent, healthy tissue, which can lead to bowel and urinary problems, as well as erectile dysfunction,”
“There is now a new technique in which a temporary gel is injected through a small needle between the prostate and rectum. The gel pushes the rectum farther from the path of the radiation treatment beam. Harmful rectal doses of radiation can be almost nil.”
– Dr. Krauss
Augmenix is excited to have Beaumont Hospital as part of the network of hospitals currently using SpaceOAR hydrogel. We look forward to assisting Beaumont Hospital in helping patients maintain their quality of life during and after radiation treatment.
“New Gel Reduces Side Effects of Prostate Cancer Treatment.” Beaumont Health, 23 Jan. 2018, www.beaumont.org/health-wellness/press-releases/new-gel-reduces-side-effects-of-prostate-cancer-treatment.